Nobel Prize for CRISPR honors two great scientists – and leaves out many others

Most scientific discoveries these days aren't easily ascribed to a single researcher. CRISPR is no different – and ongoing patent fights underscore how messy research can be.

Marc Zimmer, Professor of Chemistry, Connecticut College • conversation
Oct. 7, 2020 ~9 min

Tags: dna crispr gene-editing genome-editing crisprcas patents nobel-prize-2020 crisprcas9 yogurt nobel-prize-in-chemistry

Video: Who should get a COVID-19 vaccine first?

A bioethicist explains a recent report that recommends how to distribute a COVID-19 vaccine equitably.

Nicole Hassoun, Professor of Philosophy, Binghamton University, State University of New York • conversation
Sept. 18, 2020 ~8 min

Tags:  public-health  covid-19  coronavirus  vaccines  patents  big-pharma

When states pass social liberalization laws, they create regional advantages for innovation

Inventors in states with more socially liberal laws on the books end up with more diverse collaborators – and more higher-impact patents.

Laurina Zhang, Assistant Professor of Strategy & Innovation, Boston University • conversation
July 9, 2020 ~8 min

Tags: innovation invention entrepreneurship collaboration creativity innovation-and-invention patenting corporate-social-responsibility-csr social-policy abortion-law patents same-sex-marriage entrepreneurs medical-marijuana innovate innovation-policy corporate-social-responsibility

Page 1 of 1